WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis

Global Markets Direct, January 2009, Pages: 18

Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reasons to buy

- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.

1 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Company Snapshot 6
2.1 Key Information 6
2.2 Company Overview 6
3 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products 7
3.1 Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis 7
3.1.1 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Equipment Type 7
3.1.2 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage 7
3.1.3 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 7
3.1.4 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials 7
3.1.5 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary 8
3.2 Andara Oscillating Field Stimulator system 9
3.2.1 Product Status 9
3.2.2 Product Description 9
3.2.3 Product Milestone 10
3.2.4 Clinical Trials 10
3.3 Andara OFS Plus 11
3.3.1 Product Status 11
3.3.2 Product Description 11
3.4 BrainGate Neural Interface System 11
3.4.1 Product Status 11
3.4.2 Product Description 12
3.4.3 BrainGate Neural Interface SystemClinical Trials 1 12
3.4.4 BrainGate Neural Interface SystemClinical Trials 2 13
4 Recent Developments 14
4.1 Product News 14
4.1.1 Mar 03, 2008: Cyberkinetics Andara OFS Therapy Featured In Presentations at the AANS/CNS Meeting 14
4.1.2 Dec 11, 2007: Cyberkinetics Receives FDA Response Letter On Andara OFS System For Acute Spinal Cord Injury 14
4.1.3 Apr 11, 2007: United States Patent And Trademark Office Issues Cyberkinetics Patent For Andara OFS Therapy 14
4.1.4 Feb 20, 2007: Cyberkinetics Files To Market Andara OFS Therapy For Acute Spinal Cord Injury Under Humanitarian Device Exemption 14
5 Appendix 16
5.1 Methodology 16
5.1.1 Coverage 16
5.1.2 Secondary Research 17
5.1.3 Primary Research 17
5.1.4 Expert Panel Validation 18
5.2 Contact Us 18
5.3 About us18
5.4 Disclaimer 18

Executive Summary

1.2 List of Figures
Figure 1: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary 8
Figure 2: Global Markets Direct Methodology 16

The following companies are the major competitors of Cyberkinetics Neurotechnology Systems, Inc.:
GE Healthcare
Medtronic, Inc.
Neural Signals, Inc.
NeuroMetrix, Inc.

Customers who bought this item also bought